Analysis of relationship between peak inspiratory flow rate and amount of drug delivered to lungs following inhalation of fluticasone propionate with a Diskhaler

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 1, 2007, Pages 162-164

  Yokoyama, Haruko ^a   Yamamura, Yoshikazu ^b   Ozeki, Takeshi ^a   Iga, T ^c   Yamada, Yasuhiko ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b Yokohama Postal Service Agency Hospital   (Japan)

^c INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Diskhaler; Drug delivered to lung; Dry powder inhaler; Fluticasone propionate; Inspiratory flow rate

Indexed keywords

FLUTICASONE PROPIONATE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRY POWDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INHALER; INSPIRATORY CAPACITY; RESPIRATORY AIRFLOW; SIMULATION;

ADMINISTRATION, INHALATION; ANDROSTADIENES; ASTHMA; BRONCHODILATOR AGENTS; HUMANS; INHALATION; INSPIRATORY CAPACITY; LUNG; MODELS, BIOLOGICAL; NEBULIZERS AND VAPORIZERS; POWDERS;

EID: 33846060808     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.162     Document Type: Article

References (12)

1. Teramoto S., Tanaka Y., Hashimoto M., Fujii I., Suzuki K., Tanaka S., Oashi K., Saikai T., Abe S., Sugawara Y., Tsunematsu K., Jpn. J. Allergol., 51, 910 (2002).
2. Olsson B., J. Aerol. Med., 8, S13-19 (1995).
3. de Boer A. H., Gjaltema D., Hagedoorn P., Int. J. Pharm., 138, 45-56 (1996).
4. Steckel H., Muller B. W., Int. J. Pharm., 154, 19-29 (1997).
5. Pburnell P. K., Small T., Doig S., Johal B., Jenkins R., Gibson G. J., Resp. Med., 95, 324-330 (2001).
6. Prime D., Grant A. C., Slater A. L., Woodhouse R. N., J. Aerosol. Med., 12, 75-84 (1999).
7. Drug Information Booklet of Flutide® Rotadisk®.
8. Miyakawa T., Pediatric, 45, 1151-1157 (2004).
9. Yokoyama H., Yamada Y., Yamamura Y., Nakamura H., Iga T., Yakugaku Zasshi, 121, 233-237 (2001).
10. Smith I. J., Parry-Billings M., Pulm. Pharmacol. Ther., 16, 79-95 (2003).
11. Mackie A. E., Falcoz C., Mcdowall J. E., Moss J., Ventresca G. P., Bye A., Br. J. Clin. Pharmacol., 43, 540-541 (1997).
12. Melchor R., Biddiscombe M. F., Mak V. H. F., Short M. D., Spiro S. G., Thorax, 48, 506-511 (1993).